2000
DOI: 10.1093/jn/130.3.664s
|View full text |Cite
|
Sign up to set email alerts
|

Soybean Isoflavones as an Alternative to Traditional Hormone Replacement Therapy: Are We There Yet?

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
9
0

Year Published

2002
2002
2020
2020

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 22 publications
(9 citation statements)
references
References 18 publications
0
9
0
Order By: Relevance
“…Standard (estrogen combinations) hormone replacement therapy has some adverse effects that make the benefi t/risk profi le questionable for some patients. This subgroup can profi t from the slight effects of phytoestrogens [14] . However, the results from clinical trials are inconsistent.…”
Section: Discussionmentioning
confidence: 99%
“…Standard (estrogen combinations) hormone replacement therapy has some adverse effects that make the benefi t/risk profi le questionable for some patients. This subgroup can profi t from the slight effects of phytoestrogens [14] . However, the results from clinical trials are inconsistent.…”
Section: Discussionmentioning
confidence: 99%
“…Several studies have reviewed the use of soy for HRT (Burke et al, 2000;Kronenberg and Fugh-Berman, 2002). A double-blind parallel multi-center randomized placebo controlled trial of 104 postmenopausal women who took 60 g of isolated soy protein daily (76 mg of isoflavones) versus placebo reported that the mean number of daily hot flushes were significantly reduced in the group consuming soy ( p < 0.01) (Albertazzi et al, 1998).…”
Section: Soymentioning
confidence: 99%
“…They bind strongly to oestrogen β receptors and weakly to oestrogen α receptors, thus exerting organ-specific oestrogenic or anti-oestrogenic activity by blocking the oestrogen receptor and possessing weak oestrogenic activity [10]. Their high consumption in the Japanese population was credited for lower rates of cardiovascular diseases, breast and endometrial cancer mortality and reduced vasomotor symptoms [11]. This led to the widespread use of non-hormonal therapies based on soy isoflavones for the management of menopausal symptoms though scientific evidence for their efficacy is mixed [12].…”
Section: Introductionmentioning
confidence: 99%